1. Home
  2. IKT vs AFBI Comparison

IKT vs AFBI Comparison

Compare IKT & AFBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • AFBI
  • Stock Information
  • Founded
  • IKT 2008
  • AFBI 1928
  • Country
  • IKT United States
  • AFBI United States
  • Employees
  • IKT N/A
  • AFBI N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • AFBI Major Banks
  • Sector
  • IKT Health Care
  • AFBI Finance
  • Exchange
  • IKT Nasdaq
  • AFBI Nasdaq
  • Market Cap
  • IKT 140.5M
  • AFBI 117.2M
  • IPO Year
  • IKT 2020
  • AFBI N/A
  • Fundamental
  • Price
  • IKT $1.94
  • AFBI $18.97
  • Analyst Decision
  • IKT Buy
  • AFBI
  • Analyst Count
  • IKT 2
  • AFBI 0
  • Target Price
  • IKT $8.00
  • AFBI N/A
  • AVG Volume (30 Days)
  • IKT 529.3K
  • AFBI 4.0K
  • Earning Date
  • IKT 08-13-2025
  • AFBI 07-25-2025
  • Dividend Yield
  • IKT N/A
  • AFBI 8.03%
  • EPS Growth
  • IKT N/A
  • AFBI N/A
  • EPS
  • IKT N/A
  • AFBI 0.91
  • Revenue
  • IKT N/A
  • AFBI $31,043,000.00
  • Revenue This Year
  • IKT N/A
  • AFBI N/A
  • Revenue Next Year
  • IKT N/A
  • AFBI N/A
  • P/E Ratio
  • IKT N/A
  • AFBI $20.53
  • Revenue Growth
  • IKT N/A
  • AFBI 4.89
  • 52 Week Low
  • IKT $1.12
  • AFBI $17.00
  • 52 Week High
  • IKT $4.20
  • AFBI $22.50
  • Technical
  • Relative Strength Index (RSI)
  • IKT 52.68
  • AFBI 61.14
  • Support Level
  • IKT $1.81
  • AFBI $18.37
  • Resistance Level
  • IKT $2.09
  • AFBI $18.93
  • Average True Range (ATR)
  • IKT 0.14
  • AFBI 0.23
  • MACD
  • IKT 0.02
  • AFBI 0.02
  • Stochastic Oscillator
  • IKT 71.70
  • AFBI 60.66

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About AFBI Affinity Bancshares Inc. (MD)

Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.

Share on Social Networks: